ENVX.NASDAQEnovix CORP
10-K/A: Enovix Amends 10-K for Auditor Consent Correction
Sentiment:
Amendment to Annual Report
Enovix Corporation filed an amendment to its annual report to correct an oversight in its auditor's consent, specifically adding references to certain S-3 registration statements.
Capital raiseThe amendment corrects an oversight by including references to effective Registration Statements on Form S-3 (Nos. 333-275524, 333-273858, and 333-281260).Form S-3 registration statements are typically used by eligible companies for efficient registration of securities for potential future offerings, which may include capital raises.The filing also references Registration Statements on Form S-8 (Nos. 333-285209, 333-281261, 333-273847, 333-267050, and 333-259730), which are used for securities offered to employees through benefit plans.
Summary
- Enovix Corporation filed an Amendment No. 1 on Form 10-K/A to its Annual Report on Form 10-K for the fiscal year ended December 28, 2025.
- The primary purpose of this amendment is to replace the consent of Deloitte & Touche LLP, the company's independent registered public accounting firm, which inadvertently omitted references to the company's effective Registration Statements on Form S-3 (Nos. 333-275524, 333-273858, and 333-281260) in the original filing.
- New certifications from the Principal Executive Officer, Raj Talluri, and Principal Financial Officer, Ryan Benton, are included as exhibits to this amendment.
- This amendment does not alter any financial information or other data presented in the original Form 10-K and does not reflect events occurring after the original filing date.
- As of June 27, 2025, the aggregate market value of voting and non-voting common equity held by non-affiliates was approximately $1.64 billion.
- As of February 20, 2026, there were 217,224,442 shares of common stock, par value $0.0001 per share, issued and outstanding.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative update. It corrects a minor oversight without impacting the company's operational or financial standing.
Positives
- The company is proactively addressing and correcting administrative oversights to ensure full regulatory compliance with SEC disclosure requirements.
- The amendment confirms the continued effectiveness of internal controls over financial reporting, as attested to by Deloitte & Touche LLP's consent.
Negatives
- The initial omission of S-3 registration statements in the auditor's consent indicates a minor administrative oversight in the original filing process.
Risks
- No new risks are introduced or highlighted by this administrative amendment.
Future Outlook
The filing is an administrative amendment and does not contain any new forward-looking statements or guidance.
Management Comments
- "I have reviewed this Amendment No.1 to the Annual Report on Form 10-K for the fiscal year ended December 28, 2025 of Enovix Corporation." (Raj Talluri, President and Chief Executive Officer)
- "Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report." (Raj Talluri, President and Chief Executive Officer)
- "I have reviewed this Amendment No.1 to the Annual Report on Form 10-K for the fiscal year ended December 28, 2025 of Enovix Corporation." (Ryan Benton, Chief Financial Officer)
- "Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report." (Ryan Benton, Chief Financial Officer)
Industry Context
StockSavvy.ai notes that administrative amendments like this are routine in SEC reporting, ensuring all required disclosures and consents are accurately reflected. This filing does not provide new operational or strategic insights relevant to broader industry trends or competitors, but rather reinforces the company's commitment to regulatory precision.
Comparison to Industry Standards
- Not applicable. This administrative amendment does not contain operational or financial results that can be compared to industry benchmarks or specific comparable companies.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Certification Filing | New certifications by the Principal Executive Officer (Raj Talluri) and Principal Financial Officer (Ryan Benton) pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934. | 2026-02-25 | Ensures compliance with Section 302 of the Sarbanes-Oxley Act of 2002 regarding the accuracy of the amended report. |
Stakeholder Impact
- Shareholders: Provides assurance of regulatory compliance and accurate financial reporting, as the auditor's consent is properly referenced for relevant registration statements.
- Regulatory Authorities: Demonstrates the company's commitment to fulfilling SEC disclosure requirements by correcting an administrative error.
Next Steps
- The company will file its Proxy Statement for its 2026 Annual Meeting of Stockholders with the SEC pursuant to Regulation 14A not later than 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K.
Key Dates
| Date | Description |
|---|---|
| 2020-11-25 | Specimen Warrant Certificate filed (S-1/A 333-250042) |
| 2021-02-22 | Agreement and Plan of Merger dated |
| 2021-05-10 | Forms of Stock Option Agreement, Restricted Stock Unit Grant Notice, Option Agreement, and Office Lease related documents filed |
| 2021-06-21 | Specimen Common Stock Certificate filed (S-4/A 333-253976) |
| 2021-07-19 | Second Amended and Restated Certificate of Incorporation, Amended and Restated Bylaws, Warrant Agreement, 2021 Equity Incentive Plan, 2021 Employee Stock Purchase Plan, and Form of Indemnification Agreement filed |
| 2022-03-25 | Description of Securities filed (10-K 001-39753) |
| 2022-08-16 | Forms of Restricted Stock Unit Grant Notice for Long-Term Incentive Plan Award and Restricted Stock Unit Award Agreement filed |
| 2023-03-01 | Long-Term Incentive Plan, Employment Agreement with Raj Talluri, and Employment Agreement with Ajay Marathe filed |
| 2023-04-20 | Indenture dated for 3.00% Convertible Senior Notes due 2028 |
| 2023-04-21 | Indenture and Form of Global Note for 3.00% Convertible Senior Notes due 2028, and Form of Confirmation for Capped Call Transactions filed |
| 2023-05-05 | 2023 Long-Term Incentive Plan, Form of Global RSU Award Grant Notice, and Employment Agreement with Arthi Chakravarthy filed |
| 2023-07-26 | Manufacturing Agreement dated with YBS International Berhad |
| 2023-08-09 | Manufacturing Agreement filed |
| 2023-09-18 | Stock Purchase Agreement dated with Rene Limited |
| 2023-11-09 | Stock Purchase Agreement filed |
| 2024-02-29 | Incentive Compensation Recoupment Policy filed |
| 2024-05-07 | Form of 2024 Performance Stock Unit Award Grant Notice and Agreement and Amended and Restated Non-Employee Director Compensation Policy filed |
| 2024-10-29 | Amendment No.2 to Manufacturing Agreement dated with YBS International Berhad |
| 2024-10-30 | Amendment No.2 to Manufacturing Agreement filed |
| 2025-03-14 | Employment Agreement dated with Ryan Benton |
| 2025-05-02 | Form of 2025 Performance Stock Unit Award Grant Notice and Agreement and Employment Agreement with Ryan Benton filed |
| 2025-06-27 | Aggregate market value of non-affiliate common equity was approximately $1.64 billion |
| 2025-09-15 | Indenture dated for 4.75% Convertible Senior Notes due 2030 and Form of Confirmation for Capped Call Transactions filed |
| 2025-12-28 | Fiscal year ended |
| 2026-02-20 | 217,224,442 shares of common stock issued and outstanding |
| 2026-02-25 | Original Annual Report on Form 10-K filed; Consent of Deloitte & Touche LLP dated; Amendment No. 1 on Form 10-K/A filed; Certifications of Principal Executive Officer and Principal Financial Officer dated |
Keywords
Enovix Corporation, ENVX, 10-K/A, SEC filing, auditor consent, Deloitte & Touche, Form S-3, Form S-8, financial reporting, corporate governance, amendment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.